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The Human Genome Project, completed in 2003, identi-
fied the sequence of the approximately 25,000 genes that 
comprise the human genome. Knowledge of the structure 
of the human genome opened the doors to studying the 
actual function of specific genes, which is necessary to 
understanding health and disease. DNA microarrays are 
one technique that advances understanding of the genome 
from structure to function.
For the most part, every cell in the body contains a 
complete set of identical DNA. What makes a given cell 
different from another is that only certain genes are active, 
or “expressed,” within the cell. The information contained 
within the DNA in a given cell is transcribed into 
messenger RNA (mRNA), which is subsequently translated 
into proteins that allow the cell to exist and function. 
Diseased cells may fail to work properly because they do 
not express necessary genes, express the wrong genes, 
or express inappropriate amounts of a needed gene. The 
ability to detect these abnormalities provides researchers 
with key information that may be used to diagnose and 
manage diseases.
dna micrOarraY TechnOlOGY
Microarray technology can be used for a variety of func-
tions, several of which are discussed below. For purposes 
of clarity, we focus on the use of the technique to assess 
gene expression levels.
Older techniques looking at gene expression were time-
consuming and provided information only on relatively 
few genes at one time. DNA microarrays are unique in 
that they allow scientists to investigate the expression of 
thousands of genes at one time. In addition, they permit 
simultaneous comparisons between different cells, such as 
between a diseased and a normal cell.
hOW dO micrOarraYs WOrK? The BrieF VersiOn
Microarrays are based on the principle that nucleic acid 
bases bind to their complementary bases. Known seg-
ments of DNA are used as “probes” to bind and identify 
sample mRNA. Although this is not substantially different 
from other hybridization techniques (such as Southern and 
northern blotting), what is unique about microarrays is the 
amount of information that is provided at one time. Tens 
of thousands of DNA sequences (or even larger numbers 
of oligonucleotides) are arranged in a known and orderly 
fashion (hence “array”) on a small, solid support structure 
or microchip. The test sample is allowed to bind to the 
array. If a gene in the sample is expressed, its mRNA will 
bind, or hybridize, to its complementary DNA probe on 
the chip. The array is then scanned, providing both quali-
tative and quantitative information about the function of 
specific genes. DNA microarrays allow simultaneous and 
parallel determination of the expression of numerous 
genes and are thus a powerful laboratory tool.
WHAT MICROARRAY ANALYSIS DOES
•  DNA microarrays allow the entire genome to be 
studied at one time.
•  The technique is relatively simple, with little 
“hands-on” work.
•  Microarrays offer qualitative and quantitative 
comparison of gene expression among different cells.
LIMITATIONS 
•  Inappropriately selected controls may not yield 
relevant results.
•  Tissue processing is not standardized, leading to 
the possibility of the contribution of surrounding 
nontumor tissues to gene expression profiles.
•  There is a lack of appropriate “normal” or control 
specimens.
•  Gene expression does not always correlate with 
cellular phenotype.
•  Although costs are decreasing, they have been high 
to date.
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Oligonucleotide arrays consist of probes composed 
of short nucleotides (15–25 nt) or long oligonucleotides 
(50–120 nt) that are directly synthesized onto glass slides 
or silicon wafers, using either photolithography or ink-jet 
technology. The use of longer oligonucleotides (50–100 
mers) may increase the specificity of hybridization and 
increase sensitivity of detection (Kane et al., 2000). Arrays 
fabricated by direct synthesis offer the advantage of using 
reproducible, high-density probe arrays containing more 
than 300,000 individual elements, with probes specifically 
designed to contain the most unique part of a transcript. 
This method allows for increased detection of closely 
related genes or splice variants.
The hybridization process
Whether cDNA or oligonucleotides are used as a probe, the 
test sample must be prepared. In most cases, the “target,” or 
that which should hybridize to the probe, is mRNA. This is 
extracted from the tissue, transcribed into its complementary 
cDNA, and labeled with either a fluorescent dye (“fluoro-
phore”) or a radioactive isotope. The use of different fluo-
rophores facilitates direct, parallel comparison between dif-
ferent tissue types; this technique could, for example, allow 
simultaneous comparison of known diseased versus normal 
tissue. Fluorescent dyes commonly used for cDNA labeling 
include Cy3 (which fluoresces green) and Cy5 (which fluo-
resces red). The labeled targets are hybridized to the probes 
for 16–24 hours, during which time the targets competitive-
ly bind to the corresponding array probe. The array is then 
washed and scanned using a laser confocal microscope. The 
relative fluorescence of each spot is detected and recorded. 
The data can then be analyzed to determine which genes 
are actively expressed (Figure 1). Several computing pro-
grams for image processing and data analysis are on the 
market, from both academic and private institutions (e.g., 
Biodiscovery, National Human Genome Research Institute, 
Spotfire, and Stanford University).
The type of data generated from microarrays depends on 
several factors, including the experimental design, the purity 
of samples, the quality of the microarray design, and data 
analysis. Although microarrays are capable of generating 
a large amount of data, microarray data do not distinguish 
between differences in expression that are attributable to 
experimental design and those that are secondary effects. 
Careful selection of controls and experimental samples may 
decrease the possibility of identifying irrelevant changes in 
gene expression. In addition, caution should be advised in 
interpreting genes that show no change in expression levels 
because this may reflect DNA elements on the array that 
fail to detect the appropriate transcript species. Verification 
of data generated from microarray experiments using 
quantitative reverse-transcriptase PCR, northern blot analysis, 
or RNase protection assays may be important.
uses OF micrOarraYs
Microarray technology allows simultaneous analysis of 
several thousand DNA transcripts derived from experi-
mental tissue or cells. This technique can be used to detect 
microarrays
Various microarray systems have been developed. Some 
are commercially available; others are produced primarily 
in research laboratories. The type of solid support used 
(e.g., glass or filters), the surface modifications with various 
substrates, the type of DNA fragments used on the array 
(e.g., cDNA, oligonucleotides, genomic fragments), whether 
the transcripts are synthesized in situ or presynthesized 
and spotted onto the array (i.e., spot arrays), and how DNA 
fragments are placed on the array are all characteristics that 
differentiate among the available microarrays (Holloway 
et al., 2002). There are now many commercially available 
microarrays that are of high quality and low cost.
The most common probes used on array platforms 
are complementary DNA (cDNA) or oligonucleotides. 
Ideal probes should be sequence-validated, unique, and 
representative of a significant portion of the genome, and they 
should have minimal cross-hybridization to related sequences. 
Probes for cDNA arrays are composed of cDNAs from cDNA 
libraries or clone collections (e.g., bacterial cDNA and 
bacterial artificial chromosome clone sets) that are “spotted” 
onto glass slides or nylon membranes at precise locations. 
Spotted arrays composed of a collection of cDNAs allow for 
increased choice of sequences incorporated in the array and 
may allow for gene discovery when unselected clones from 
cDNA libraries are used (Schulze and Downward, 2001).
Figure 1. The hybridization process.
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differences in gene expression levels, small nucleotide 
polymorphisms, and other sequence differences, as well 
as microRNA (miRNA) transcript levels (miRNAs are short, 
noncoding RNAs that regulate gene expression in many 
biologic processes). A microarray technique called com-
parative genomic hybridization is used to detect genom-
ic gains or losses in the number of copies of genes in a 
given person’s DNA. This technique can provide clinical 
and prognostic information in certain tumors. Microarray 
technology has also been useful in biomarker determina-
tion, enabling the discovery of gene sets that correlate with 
disease. Other uses include changes in gene expression 
following exposure to medications or toxins in order to 
predict their effectiveness or adverse effects, respectively. 
Microarrays may also be used to personalize therapy in 
patients recently diagnosed with cancer.
applicaTiOns in dermaTOlOGY
Skin biology was one of the first scientific fields to 
benefit from microarray technology. It has been applied 
to a variety of dermatologic disease processes, including 
melanoma, cutaneous T-cell lymphoma, psoriasis, 
lupus erythematosus, and scleroderma. Its application 
in the detection of different gene expression levels 
and of differences in genetic sequences—including 
single-nucleotide polymorphisms (SNPs)—as well as in 
identification of new genetic targets makes microarray 
technology very attractive. Investigators using microarrays 
to determine global miRNA expression profiles identified 
deregulation of certain miRNAs as significantly different 
among melanoma lymph node metastases, melanoma cell 
lines, and melanocyte cultures (Caramuto et al., 2010; 
Mueller et al., 2009). Moreover, a miRNA signature of high 
expression of miR-193b and low expression of miR-191 
was found to be significantly associated with poor survival 
(Caramuta et al., 2010). These studies identified previously 
unrecognized molecular targets in melanoma. Figures 2 
and 3 show examples of how the data from such arrays are 
obtained and interpreted.
Figure 2 (Caramuto et al., 2010) shows the relative 
expression of a series of miRNAs (listed on the y-axis) 
obtained from multiple nonmelanoma (NM 1–3 on 
the x-axis) and melanoma (M1–M16) cell lines. Yellow 
indicates relatively high expression; blue indicates 
low expression. Detailed analysis of the data allowed 
researchers to identify a small number of miRNAs that were 
differentially expressed in melanoma versus nonmelanoma 
cell lines (some were underexpressed; others were 
overexpressed).
As shown in Figure 3 (Caramuto et al., 2010), the 
researchers further used microarray technology to 
determine whether certain miRNA expression profiles 
(those chosen are listed on the right side of the arrays) 
could be used to discriminate among BRAF mutants 
and BRAF and NRAS wild-type mutants. The strongest 
association with BRAF mutation status was shown with 
miR-193a, whose expression was significantly reduced in 
the melanoma lines.
In inflammatory disorders, the microarray is most 
likely to be used to understand molecular pathogenesis. 
Psoriasis is a polygenic chronic inflammatory disease 
of keratinocytes in which T cells play a crucial role. 
Microarray analysis has been used since the early 2000s to 
expand the existing knowledge of gene expression patterns 
in psoriasis (Kunz, 2008). This technique can be used 
alone or in combination with other techniques. In a recent 
publication (Mitsui et al., 2012), the investigators studied 
Figure 2. relative expression of a series of micrornas. From Caramuto et al., 2010.
Figure 3. comparison of microrna expression profiles. From Caramuto et al., 2010.
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the gene expression of cells in lesional epidermis and 
dermis with the corresponding nonlesional regions. Laser-
capture microdissection (LCM) was used to sample tissue 
from the epidermis and dermis. DNA microarray analysis 
was then used to define gene expression patterns in these 
different regions of the skin. The investigators established 
the validation of combining LCM and cDNA microarray 
analysis and were able to ascertain the presence of CCL19/
CCR7 in psoriatic dermal aggregates, along with the 
presence of gene products of mature dendritic cells.
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SUPPLEMENTARY MATERIAL
Answers and a PowerPoint slide presentation appropriate for journal club 
or other teaching exercises are available at http://dx.doi.org/10.1038/
jid.2013.64.
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QUESTIONS
1.  The term “array” in microarray refers to the 
arrangement of which of the following on the chip?
A. The probe.
B.  The target.
C. The fluorophore.
D. The antigen.






3.  microarray analysis has been used to study:
A. Melanoma.
B. Psoriasis.
C. Cutaneous T-cell lymphoma.
D. Scleroderma.
E. All of the above.
Answers to the questions and an opportunity to comment on the 
article are available on our blog: http://blogs.nature.com/jid_jottings/.
